Evidence for inhibition of exodus of small neutral amino acids from non-brain tissues in hyperphenylalaninaemic rats

Journal of Inherited Metabolic Disease
C de CéspedesH N Christensen

Abstract

The mechanism of the depletion of several plasma amino acids in PKU has remained unexplained. In the present study, a statistically significant decrease in the plasma concentration of several amino acids was observed 2 h after the intraperitoneal injection of Phe to weanling rats. The pattern was very similar to the one observed in PKU patients. Statistically significant increases in the distribution ratios liver/plasma and, mainly, muscle/plasma ratios accompanied in most of the cases the corresponding decreases in plasma concentrations. Equimolar injection under the same conditions of the non-insulinogenic transport system L analogue, the a(+/-) isomer of the 2-aminonorbornane-2-carboxylic acid, produced, in a parallel effect to Phe, statistically significant increases in the distribution ratios of Ala and Gly, and probably of Pro in muscle, as well as of Ala in liver. These results seem to indicate that the high intracellular Phe attained inhibits the exodus of small neutral amino acids through system L, causing their depletion in plasma and ultimately in the brain. This effect may be additive to the inhibition by Phe of the entry of bulky neutral amino acids at the level of the blood-brain barrier. Further study is needed t...Continue Reading

References

Jan 1, 1977·Journal of Neurochemistry·W M Pardridge, W H Oldendorf
Dec 1, 1975·Journal of Neurochemistry·L A Wade, R Katzman
Jan 1, 1987·Journal of Inherited Metabolic Disease·I AntonozziR Dominici
Jan 1, 1987·Perspectives in Biology and Medicine·H N Christensen
Jun 15, 1986·The Biochemical Journal·H N Christensen
Jul 2, 1971·Biochemical and Biophysical Research Communications·H S Tager, H N Christensen
Sep 1, 1969·Canadian Journal of Biochemistry·J A Lowden, M A LaRamée
Apr 2, 1970·The New England Journal of Medicine·T L PerryS Diamond
Mar 1, 1968·Biochimica Et Biophysica Acta·H N Christensen, A M Cullen
May 24, 1983·Biochimica Et Biophysica Acta·M A ShotwellD L Oxender
Jan 1, 1981·Journal of Inherited Metabolic Disease·T Zanić-Grubisić, K Lipovac
Oct 1, 1982·Physiological Reviews·H N Christensen
Dec 4, 1980·The New England Journal of Medicine·C R Scriver, C L Clow
Jan 1, 1953·Annual Review of Biochemistry·H N CHRISTENSEN
Mar 1, 1962·Klinische Wochenschrift·F LINNEWEH, M EHRLICH
Jan 1, 1984·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·G HuetherV Neuhoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.